United States
Germany
Japan
United Kingdom
China
FGF21 mouse monoclonal antibody, clone OTI2F10 (formerly 2F10)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
Antibodies
FGF21 mouse monoclonal antibody, clone OTI1H4 (formerly 1H4)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
FGF21 mouse monoclonal antibody, clone OTI9E5 (formerly 9E5)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
FGF21 mouse monoclonal antibody, clone OTI4B2 (formerly 4B2)
| Applications | FC, IF, WB |
| Reactivities | Human |
FGF21 mouse monoclonal antibody, clone OTI4B4 (formerly 4B4)
| Applications | FC, IF, WB |
| Reactivities | Human |
FGF21 mouse monoclonal antibody, clone OTI2F10 (formerly 2F10)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
FGF21 mouse monoclonal antibody, clone OTI3E5 (formerly 3E5)
| Applications | FC, WB |
| Reactivities | Human |
FGF21 mouse monoclonal antibody, clone OTI2E2 (formerly 2E2)
| Applications | FC, IF, WB |
| Reactivities | Human |
FGF21 mouse monoclonal antibody, clone OTI9A7 (formerly 9A7)
| Applications | FC, WB |
| Reactivities | Human |
FGF21 mouse monoclonal antibody, clone OTI1A9 (formerly 1A9)
| Applications | FC, WB |
| Reactivities | Human |
FGF21 mouse monoclonal antibody, clone OTI3G9 (formerly 3G9)
| Applications | FC, WB |
| Reactivities | Human |
FGF21 mouse monoclonal antibody, clone OTI1B4 (formerly 1B4)
| Applications | FC, WB |
| Reactivities | Human |
FGF21 mouse monoclonal antibody, clone OTI1H5 (formerly 1H5)
| Applications | FC, WB |
| Reactivities | Human |
FGF21 mouse monoclonal antibody, clone OTI2B9 (formerly 2B9)
| Applications | FC, WB |
| Reactivities | Human |
FGF21 mouse monoclonal antibody, clone OTI2F8 (formerly 2F8)
| Applications | IF, WB |
| Reactivities | Human |
